Antiepileptogenic Effect of Retinoic Acid.

Artemio Rosiles-Abonce, Carmen Rubio, Elisa Taddei, Dulce Rosiles, Moisés Rubio-Osornio

Journal: Current neuropharmacology 2021;19(3):383-391

PMID: 32351181

Abstract

Retinoic acid, a metabolite of vitamin A, acts through either genomic or nongenomic actions. The genomic action of retinoids exerts effects on gene transcription through interaction with retinoid receptors such as retinoic acid receptors (RARα, β, and γ) and retinoid X receptors (RXRα, β, and γ) that are primarily concentrated in the amygdala, pre-frontal cortex, and hippocampal areas in the brain. In response to retinoid binding, RAR/RXR heterodimers undergo major conformational changes and orchestrate the transcription of specific gene networks. Previous experimental studies have reported that retinoic acid exerts an antiepileptogenic effect through diverse mechanisms, including the modulation of gap junctions, neurotransmitters, long-term potentiation, calcium channels and some genes. To our knowledge, there are no previous or current clinical trials evaluating the use of retinoic acid for seizure control.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurologia y Neurocirugia, Ciudad de Mexico, Mexico.; Departamento de Neurofisiologia, Instituto Nacional de Neurologia y Neurocirugia, Ciudad de Mexico, Mexico.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.